NOVELION THERAPEUTICS INC.
Healthcare · Pharmaceutical Preparations · A1 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $130.4M | $138.4M | — | — | — | — |
| Operating income | −$21.5M | −$21.7M | −$8.9M | −$23.3M | −$3.8M | −$28.5M |
| Net income | −$32.8M | −$31.0M | −$21.9M | −$23.0M | −$4.1M | −$24.9M |
| Total assets | $341.7M | $369.3M | $480.8M | $145.2M | $160.4M | $163.9M |
| Total liabilities | $430.6M | $354.4M | $345.0M | $3.8M | $3.9M | $6.1M |
| Equity | −$88.9M | $14.9M | $135.8M | $141.3M | $156.5M | $157.8M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 18.7M | 18.6M | 52.8M | 51.3M | 51.1M | 50.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- −16.5%
- Net margin
- −25.2%
- Return on equity
- 36.9%
- Return on assets
- −9.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 126.0%
- Debt / equity
- —
- Book value / share
- $-4.75
- Revenue growth (YoY)
- −5.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- -14.39distress
- Accruals / assets
- 6.6%moderate
- Beneish M-Score
- -2.08normal
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 30, 2020
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2019
- NT 10-Qmissed a reporting deadline ↗Aug 12, 2019
- NT 10-Kmissed a reporting deadline ↗Mar 13, 2017
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Other material eventJul 14, 2020
- Other material eventJun 12, 2020
- Bankruptcy or receivership · Director / officer change · Other material eventJan 21, 2020
- Other material eventJan 10, 2020
- Director / officer change · Other material eventJan 3, 2020
- Regulation FD disclosureDec 11, 2019
- Other material eventNov 22, 2019
- Shareholder vote · Other material eventNov 5, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDMar 10, 2023
- 8-KFORM 8-KJul 14, 2020
- 8-KFORM 8-KJun 12, 2020
- NT 10-KMar 30, 2020
- SC 13G/AFeb 13, 2020
- 8-KFORM 8-KJan 21, 2020
- SC 13G/AJan 21, 2020
- 3Jan 15, 2020
- SC 13G/AJan 15, 2020
- SC 13G/AJan 10, 2020
- 8-KFORM 8-KJan 10, 2020
- 8-KFORM 8-KJan 3, 2020
- 25-NSEDec 17, 2019
- 4FORM 4Dec 12, 2019
- 8-KFORM 8-KDec 11, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.